Actionable news
0
All posts from Actionable news
Actionable news in ABBV: ABBVIE Inc,

FDA accepts AbbVie's NDA for once-daily V-Pak

The FDA accepts for review AbbVie's (NYSE:ABBV) New Drug Application (NDA) for a once-daily, fixed-dose formulation of the components of VIEKIRA PAK (ombitasvir, paritaprevir and ritonavir tablets;...


More